Latest News

This biotech stock soared 20% last week — and analysts are giving it another 36% upside

0

U.S. biotech firm Horizon Therapeutics was among the top global performers last week, with its stock soaring nearly 21% for the week. The company, which produces treatments for people with autoimmune and severe inflammatory diseases, reported earnings last week. It raised its full-year 2022 net sales guidance to a range of between $3.59 billion and $3.61 billion. Its previous range was $3.53 billion to $3.6 billion. Analysts covering the stock are positive on its future performance, with nearly 87% giving it a “buy” rating and price target upside of 36%. The stock was trading around $77 as of Friday’s close. Horizon Therapeutics also raised its guidance for 2022 earnings before interest, taxes, depreciation and amortization — to between $1.32 billion and $1.34 billion, down from the previous range of $1.268 billion to $1.318 billion. The stock bucked the trend of a decline in global stocks last week, with the MSCI World Index dipping around 2% for the week. Still, seven global stocks, including Horizon, soared more than 20%. These are the seven stocks under the MSCI World Index. Abiomed has the largest gain of 44.9% thanks to news earlier last week that it’s set to be bought by Johnson & Johnson in a $16.6 billion deal . J & J agreed to pay $380 per Abiomed share, a 50.7% premium over Monday’s closing price of $252.08. In addition, shareholders of Abiomed shareholders have the right to receive up to $35 per share in cash if certain clinical and commercial milestones are achieved. British online grocery tech business Ocado was the next top gainer, jumping nearly 35%. Its shares surged after it entered into a deal with South Korea’s Lotte Shopping . Analysts covering the stock gave it an upside of 50%. Tech investment firm Prosus jumped 21%. The Amsterdam-listed firm and its South African parent Naspers were reportedly in talks to sell their large stake in Chinese tech giant Tencent, but they denied it last week. — CNBC’s Michelle Fox contributed to this report.

China’s exports unexpectedly shrink in October, badly missing expectations for growth

Previous article

IMF chief says rich countries alone can ‘never close’ the funding gap for climate change

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News